CLINICAL_TRIALS
trial_result
· 2014-05-21
Clinical Trial Update: EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine [Phase 1]
Summary
Phase 1 trial assessing safety and immunogenicity of the EuroNeut41 HIV vaccine has been completed. The study was sponsored by PX'Therapeutics.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PX'Therapeutics | Conditions: HIV | Phase 1 | Status: COMPLETED